REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $36,000 | +28.6% | 20,000 | 0.0% | 0.01% | +14.3% |
| Q2 2018 | $28,000 | -6.7% | 20,000 | 0.0% | 0.01% | -12.5% |
| Q1 2018 | $30,000 | -25.0% | 20,000 | 0.0% | 0.01% | -20.0% |
| Q4 2017 | $40,000 | -16.7% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q3 2017 | $48,000 | -15.8% | 20,000 | 0.0% | 0.01% | -25.0% |
| Q2 2017 | $57,000 | -44.1% | 20,000 | -90.0% | 0.02% | -42.9% |
| Q1 2017 | $102,000 | +264.3% | 200,000 | 0.0% | 0.03% | +250.0% |
| Q4 2016 | $28,000 | -33.3% | 200,000 | 0.0% | 0.01% | -38.5% |
| Q3 2016 | $42,000 | -16.0% | 200,000 | 0.0% | 0.01% | -18.8% |
| Q2 2016 | $50,000 | -24.2% | 200,000 | 0.0% | 0.02% | -23.8% |
| Q1 2016 | $66,000 | -9.6% | 200,000 | 0.0% | 0.02% | -8.7% |
| Q4 2015 | $73,000 | -40.2% | 200,000 | 0.0% | 0.02% | -39.5% |
| Q2 2015 | $122,000 | – | 200,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northeast Financial Consultants Inc | 150,000 | $130,000 | 0.07% |
| Benin Management CORP | 83,000 | $72,000 | 0.04% |
| CONDOR CAPITAL MANAGEMENT | 114,987 | $100,000 | 0.03% |
| FIRST NEW YORK SECURITIES LLC /NY | 15,000 | $13,050,000 | 0.01% |
| Advisory Services Network, LLC | 22,000 | $19,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $157,000 | 0.00% |
| Moors & Cabot, Inc. | 25,000 | $22,000 | 0.00% |
| Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,566 | $4,000 | 0.00% |
| AQR Capital Management | 213,900 | $186,000 | 0.00% |